Bandaríkin - enska - NLM (National Library of Medicine)

mayne pharma inc - vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol (unii: h4n855pnz1) (.alpha.-tocopherol - unii:h4n855pnz1), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x5 - vitamin a 1500 [iu] in 1 ml - supplementation of the diet with nine essential vitamins. supplementation of the diet with fluoride for caries prophylaxis. the american academy of pediatrics recommends that children up to age 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplementation. multivitamin and fluoride supplemental drops 0.5 mg provide fluoride in drop form for infants and young children 6 months to 3 years of age, in areas where the drinking water contains less than 0.3 ppm of fluoride and for children ages 3-6 years, in areas where the drinking water contains 0.3 through 0.6 ppm of fluoride. each 1.0 ml supplies sodium fluoride (0.5 mg fluoride) plus nine essential vitamins. the american academy of pediatrics recommended that infants and young children 6 months to 3 years of age, in areas where drinking water contains less than 0.3 ppm of fluoride, and children 3-6, years of age, in areas where the drinking water contains 0.3 through 0.6 ppm of fluoride, receive 0.25

Bandaríkin - enska - NLM (National Library of Medicine)

mayne pharma inc - vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol (unii: h4n855pnz1) (.alpha.-tocopherol - unii:h4n855pnz1), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x5 - vitamin a 1500 [iu] in 1 ml - supplementation of the diet with eight essential vitamins and iron, plus fluoride. supplementation of the diet with fluoride for caries prophylaxis. the american academy of pediatrics recommends that children up to age 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplementation. multi vitamin, iron and fluoride supplemental drops 0.25 provide fluoride in drop form for children ages 2-3 years where the drinking water contains less than 0.3 ppm of fluoride and for children over 3 years, in areas where the drinking water contains 0.3 through 0.7 ppm of fluoride. each 1.0 ml provides sodium fluoride (0.25 mg fluoride) plus eight essential vitamins and iron. the american academy of pediatrics and the american dental association currently recommend that infants and children under 2 years of age, in areas where drinking water contains less than 0.3 ppm of fluoride, and children 2-3, years of age, in areas where the drinking water contains 0.3 through 0.7

Evrópusambandið - sænska - EMA (European Medicines Agency)

ceva santé animale - tulatromycin - antibakteriella medel för systemisk användning - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. förekomsten av sjukdomen i besättningen bör fastställas före metafylaktisk behandling. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. förekomsten av sjukdomen i besättningen bör fastställas före metafylaktisk behandling. the product should only be used if pigs are expected to develop the disease within 2–3 days. får: behandling av de tidiga stadierna av infektiös pododermatit (fotrot) i samband med virulent dichelobacter nodosus som kräver systemisk behandling.

Holland - hollenska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

novartis pharma b.v. haaksbergweg 16 1101 bx amsterdam - estradiol 0,5-water samenstelling overeenkomend met ; estradiol - pleister voor transdermaal gebruik - acrylaatkleefstof gelva 788 ; copolymeer van ethyleen-vinylacetaat (28 pct. vinylacetaat) ; copolymer of vinylchloride/vinylidenechloride (ri) ; dipropyleenglycol ; fluoropolymer (ri) ; oleylalcohol ; polyethyleen ; povidon (e 1201) ; siliciumdioxide (e 551) ; silicone adhesive bio-psa 7-4502 (ri) ; titaandioxide (e 171), - estradiol

Holland - hollenska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

novartis pharma b.v. haaksbergweg 16 1101 bx amsterdam - estradiol 0,5-water samenstelling overeenkomend met ; estradiol - pleister voor transdermaal gebruik - acrylaatkleefstof gelva 788 ; copolymeer van ethyleen-vinylacetaat (28 pct. vinylacetaat) ; copolymer of vinylchloride/vinylidenechloride (ri) ; dipropyleenglycol ; fluoropolymer (ri) ; oleylalcohol ; polyethyleen ; povidon (e 1201) ; siliciumdioxide (e 551) ; silicone adhesive bio-psa 7-4502 (ri) ; titaandioxide (e 171), - estradiol

Holland - hollenska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

novartis pharma b.v. haaksbergweg 16 1101 bx amsterdam - estradiol 0,5-water samenstelling overeenkomend met ; estradiol - pleister voor transdermaal gebruik - acrylaatkleefstof gelva 788 ; copolymeer van ethyleen-vinylacetaat (28 pct. vinylacetaat) ; copolymer of vinylchloride/vinylidenechloride (ri) ; dipropyleenglycol ; fluoropolymer (ri) ; oleylalcohol ; polyethyleen ; povidon (e 1201) ; siliciumdioxide (e 551) ; silicone adhesive bio-psa 7-4502 (ri) ; titaandioxide (e 171), - estradiol

Holland - hollenska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

novartis pharma b.v. haaksbergweg 16 1101 bx amsterdam - estradiol 0,5-water samenstelling overeenkomend met ; estradiol - pleister voor transdermaal gebruik - acrylaatkleefstof gelva 788 ; copolymeer van ethyleen-vinylacetaat (28 pct. vinylacetaat) ; copolymer of vinylchloride/vinylidenechloride (ri) ; dipropyleenglycol ; fluoropolymer (ri) ; oleylalcohol ; polyethyleen ; povidon (e 1201) ; siliciumdioxide (e 551) ; silicone adhesive bio-psa 7-4502 (ri) ; titaandioxide (e 171), - estradiol

Holland - hollenska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

novartis pharma b.v. haaksbergweg 16 1101 bx amsterdam - estradiol 0,5-water samenstelling overeenkomend met ; estradiol - pleister voor transdermaal gebruik - acrylaatkleefstof gelva 788 ; copolymeer van ethyleen-vinylacetaat (28 pct. vinylacetaat) ; copolymer of vinylchloride/vinylidenechloride (ri) ; dipropyleenglycol ; fluoropolymer (ri) ; oleylalcohol ; polyethyleen ; povidon (e 1201) ; siliciumdioxide (e 551) ; silicone adhesive bio-psa 7-4502 (ri) ; titaandioxide (e 171), - estradiol

Holland - hollenska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

intervet nederland b.v. - cefquinome - suspensie voor injectie - cefquinome 25 mg/ml, - cefquinome - runderen; varkens

Evrópusambandið - sænska - EMA (European Medicines Agency)

virbac s.a. - tulatromycin - antibakteriella medel för systemisk användning - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. förekomsten av sjukdomen i besättningen bör fastställas före metafylaktisk behandling. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. förekomsten av sjukdomen i besättningen bör fastställas före metafylaktisk behandling. the product should only be used if pigs are expected to develop the disease within 2–3 days. får: behandling av de tidiga stadierna av infektiös pododermatit (fotrot) i samband med virulent dichelobacter nodosus som kräver systemisk behandling.